Galina N. Svetlova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Galina N. Svetlova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
A. V. Djubailo
Samara State Medical University
1 shared publication- Andrey A. Knyazev
Samara State Medical University of the Ministry of Health of the Russian Federation
1 shared publication - Dmitry Kudashev
Samara State Medical University
1 shared publication - Evgenii I. Pugachev
Samara State Medical University
1 shared publication - Irina А. Shafieva
Clinics of the Samara State Medical University
1 shared publication - Larisa Teodorovna Volova
Samara State Medical University
1 shared publication
Latest Publications
- Open Access
- 6 May 2024
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 9 (1) , 14-21
In vitro cell-based Hyperuricemia-hemotest bioassay for cytokine status evaluation in patients with gouty arthritis
Aim– to develop anin vitromethod for assessing the activity of the inflammasome under conditions of hyperuricemic stimulation of inflammatory interleukins. Material and methods.Whole blood cells of donors and patients with hyperuricemia and exacerbation of gouty arthritis diluted with RPMI were culturedin vitroin the presence of different concentrations of uric acid. The production of cytokines in the cell growth media of hematopoietic cells stimulated with uric acid was evaluated using an enzyme-linked immunosorbent assay (ELISA). Results.By simulating the hyperuricemiain vivo, anin vitrocell-based bioassay was developed to stimulate blood cells of individual donors with uric acid. Using the developedin vitroHyperuricemia-hemotest bioassay, quantitative differences were found in the production of inflammatory cytokines by the blood cells of potentially healthy donors and patients with hyperuricemia and gouty arthritis. Conclusion.As a new approach in personalized diagnostics, a hyperuricemic (HU)-hemotest system was developed, which can serve as anin vitrocell model for studying the activation of inflammasome by inflammatory signaling molecules in gouty arthritis.
- 6 May 2024
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 9 (1) , 14-21
Open AccessIn vitro cell-based Hyperuricemia-hemotest bioassay for cytokine status evaluation in patients with gouty arthritis
Aim– to develop anin vitromethod for assessing the activity of the inflammasome under conditions of hyperuricemic stimulation of inflammatory interleukins. Material and methods.Whole blood cells of donors and patients with hyperuricemia and exacerbation of gouty arthritis diluted with RPMI were culturedin vitroin the presence of different concentrations of uric acid. The production of cytokines in the cell growth media of hematopoietic cells stimulated with uric acid was evaluated using an enzyme-linked immunosorbent assay (ELISA). Results.By simulating the hyperuricemiain vivo, anin vitrocell-based bioassay was developed to stimulate blood cells of individual donors with uric acid. Using the developedin vitroHyperuricemia-hemotest bioassay, quantitative differences were found in the production of inflammatory cytokines by the blood cells of potentially healthy donors and patients with hyperuricemia and gouty arthritis. Conclusion.As a new approach in personalized diagnostics, a hyperuricemic (HU)-hemotest system was developed, which can serve as anin vitrocell model for studying the activation of inflammasome by inflammatory signaling molecules in gouty arthritis.
- 25 April 2024
- Published by ECO-Vector LLC in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 31 (1) , 91-100
Avascular necrosis of the femoral head in combination with septic arthritis of the hip joint
BACKGROUND: The combined course of avascular necrosis of the femoral head and septic arthritis of the hip joint is extremely rare and not always timely diagnosed. Analysis of specialized foreign literature revealed only single descriptions of clinical cases of combined lesions of the hip joint (avascular necrosis of the femoral head and septic arthritis). However, these studies do not describe the surgical treatment algorithms of patients. While analyzing the sources of domestic literature for the last 10 years, we did not encounter descriptions of such clinical cases. CLINICAL CASE DESCRIPTION: A 38-year-old patient was diagnosed with avascular necrosis of the femoral head with concomitant septic arthritis of the hip joint. During the preoperative period, a diagnostic puncture of the hip joint with subsequent cytologic and microbiological examination of synovial fluid was performed. Growth of the Staphylococcus aureus strain was observed. Because primary hip arthroplasty was contraindicated and isolated conservative treatment of bacterial arthritis aggravated the course of avascular necrosis, the patient underwent two-stage surgical treatment. The first stage was femoral head resection with installation of a spherical cement spacer impregnated with antibiotics, and the second stage was total hip arthroplasty after the inflammatory process had subsided. The postoperative period of each surgical stage proceeded without complications. It was possible to achieve microorganism eradication; eliminate the chronic inflammatory process, which was confirmed clinically and laboratory; ensure the possibility of total hip arthroplasty; and restore the limb-bearing capacity, extent of motion in the joint, and quality of life of the patient. CONCLUSION: The clinical observation confirms the need for detailed diagnosis in patients with an atypical course of avascular necrosis of the femoral head and demonstrates a successful treatment option in such cases.
- 25 April 2024
- Published by ECO-Vector LLC in N.N. Priorov Journal of Traumatology and Orthopedics
- Vol. 31 (1) , 91-100
Avascular necrosis of the femoral head in combination with septic arthritis of the hip joint
BACKGROUND: The combined course of avascular necrosis of the femoral head and septic arthritis of the hip joint is extremely rare and not always timely diagnosed. Analysis of specialized foreign literature revealed only single descriptions of clinical cases of combined lesions of the hip joint (avascular necrosis of the femoral head and septic arthritis). However, these studies do not describe the surgical treatment algorithms of patients. While analyzing the sources of domestic literature for the last 10 years, we did not encounter descriptions of such clinical cases. CLINICAL CASE DESCRIPTION: A 38-year-old patient was diagnosed with avascular necrosis of the femoral head with concomitant septic arthritis of the hip joint. During the preoperative period, a diagnostic puncture of the hip joint with subsequent cytologic and microbiological examination of synovial fluid was performed. Growth of the Staphylococcus aureus strain was observed. Because primary hip arthroplasty was contraindicated and isolated conservative treatment of bacterial arthritis aggravated the course of avascular necrosis, the patient underwent two-stage surgical treatment. The first stage was femoral head resection with installation of a spherical cement spacer impregnated with antibiotics, and the second stage was total hip arthroplasty after the inflammatory process had subsided. The postoperative period of each surgical stage proceeded without complications. It was possible to achieve microorganism eradication; eliminate the chronic inflammatory process, which was confirmed clinically and laboratory; ensure the possibility of total hip arthroplasty; and restore the limb-bearing capacity, extent of motion in the joint, and quality of life of the patient. CONCLUSION: The clinical observation confirms the need for detailed diagnosis in patients with an atypical course of avascular necrosis of the femoral head and demonstrates a successful treatment option in such cases.
- 1 January 2018
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 8 (1) , 33-36
Community-Acquired Bacterial Pneumonia and Comorbidity in Elderly Patients
We have analyzed the clinical course of pneumonia in 67 elderly patients (39 women and 28 men, the average age: 74.4 ± 5.2 years) with chronic heart failure and chronic obstructive pulmonary disease...
- 1 January 2018
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 8 (1) , 33-36
Community-Acquired Bacterial Pneumonia and Comorbidity in Elderly Patients
We have analyzed the clinical course of pneumonia in 67 elderly patients (39 women and 28 men, the average age: 74.4 ± 5.2 years) with chronic heart failure and chronic obstructive pulmonary disease...